Mutual Of America Capital Management LLC Editas Medicine, Inc. Transaction History

Mutual Of America Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$20.48 - $27.76 $1.38 Million - $1.87 Million	-67,458 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$19.43 - $26.41 $23,762 - $32,299	1,223 Added 1.85%	67,458 $1.65 Million
Q3 2018 Nov 13, 2018	BUY	$27.65 - $38.39 $389,865 - $541,299	14,100 Added 27.05%	66,235 $2.11 Million
Q2 2018 Aug 09, 2018	BUY	$31.4 - $41.01 $1.64 Million - $2.14 Million	52,135 New	52,135 $1.87 Million

228

54.2M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.